Cori Clinical has raised $4.0M in a Seed round led by Breega with participation from Enzo, Heartfelt, Together Ventures and Bynd. The AI clinical trial platform is already working with two of the world's five largest CROs and counts Erasmus MC among its customers, where it supported two trials in neurosurgery and neuro-oncology; based on internal modelling the company estimates its platform can reduce average trial set-up costs by at least 33% and says its AI reviewer identified 82% of avoidable protocol errors in an internal evaluation. The company will use the seed funding to expand delivery capacity, grow its team, deepen regulatory and clinical intelligence within its platform, and build broader commercial relationships with CROs.